Position in ABBV
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$8,687,871
+$1,004,167 QoQ
Shares Held
34,525
-2.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.64%
of 13F equity value
Holder Rank
#996
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Mar 31, 2025CallValue
$1,166,144
CallShares
1,184,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Columbia Asset Management holds $59,491,013 across 10 Drug Manufacturers - General names. ABBV ranks #4 (14.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
110,475 | $14,196,037 | |
| 2 | JNJ |
Johnson & Johnson
|
51,192 | $13,001,232 | |
| 3 | LLY |
ELI LILLY & Co
|
8,009 | $9,606,235 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
34,525 | $8,687,871 | |
| 5 | AMGN |
Amgen Inc
|
21,458 | $7,770,370 | |
| 6 | PFE |
Pfizer Inc
|
190,168 | $4,579,245 | |
| 7 | AZN |
Astrazeneca PLC
|
3,589 | $680,546 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,985 | $377,124 |
All Filings in ABBV
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,687,871 | 34,525 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $7,683,704 | 35,329 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $8,107,739 | 35,484 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $8,266,904 | 35,704 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $6,771,046 | 36,478 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $7,825,991 | 37,352 | Shares | Sole | 2025-04-10 | |
| 2025-03-31 | $1,166,144 | 1,184,000 | Call | Sole | 2025-04-10 | |
| 2024-12-31 | $6,869,171 | 38,656 | Shares | Sole | 2025-02-12 | |
| 2024-12-31 | $831,981 | 844,000 | Call | Sole | 2025-02-12 | |
| 2024-09-30 | $8,052,839 | 40,778 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $6,952,906 | 40,537 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $6,255 | 40,365 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $6,255,364 | 40,365 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $6,027,390 | 40,436 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,497,253 | 40,802 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,376,599 | 46,286 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,619,911 | 47,150 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $6,363,567 | 47,415 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $7,452,459 | 48,658 | Shares | Sole | 2022-08-26 | |
| 2021-12-31 | $7,530,000 | 55,613 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,950,972 | 55,168 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $6,126,151 | 54,387 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $6,723,383 | 62,127 | Shares | Sole | 2021-05-28 | |
| 2020-12-31 | $6,028,259 | 56,260 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $4,826,646 | 55,105 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $5,521,054 | 56,234 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $7,686,732 | 100,889 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||